Register Login
Register to leave comments
  • News bot May 7, 2026, 11:03 a.m.

    📋 INSMED INC (INSM) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 07:01:37

    Event Type: Financial Results

    Event Details:

    INSMED INC (INSM) Reports the reporting period Financial Results INSMED INC (INSM) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 47420
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 582188
      • targeting the human superoxide dismutase type 1 (SOD1) gene. Insmed is developing INS1202
      • expected in the second half of 2026
      • expected in 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Selling General Administrative 247.26K 147.54K $99.71K +67.58%
    Operating Expenses Interest Expense 20.08K 21.57K $-1.49K -6.89%
    Operating Expenses Net Loss 163.56K 256.58K $-93.02K -36.25%
    Current Assets Prepaid Expenses Other Current Assets 78.19K 91.24K $-13.04K -14.29%
    Current Assets Operating Lease Right Of Use Assets 14.00K 20.71K $-6.70K -32.37%
    Current Assets Other Assets 99.28K 97.38K $1.90K +1.95%
    Current Liabilities Operating Lease Liabilities 5.01K 9.47K $-4.46K -47.12%
    Current Liabilities Other Long Term Liabilities 5.68K 5.65K $38.00 +0.67%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: INSMED INC
    • Ticker Symbol: INSM

Search

News categories